Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Par Health clinical trials
The registry lists 41 studies whose lead sponsor is Par Health or one of 3 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2017.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Par Health.
- Par Pharmaceutical, Inc.36 studies →Acquired — became part of Par Health, Nov 10, 2025 · source ↗
Something wrong?
- JHP Pharmaceuticals LLC3 studies →Acquired — became part of Par Health, Nov 10, 2025 · source ↗
Something wrong?
- Anchen Pharmaceuticals, Inc2 studies →Acquired — became part of Par Health, Nov 10, 2025 · source ↗
Something wrong?
Focus areas
Conditions Par Health leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 41 of 41.
- Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic DermatitisCompletedNCT03297502Phase 3
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed ConditionsCompletedNCT00652873Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed ConditionsCompletedNCT00652730Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed ConditionsCompletedNCT00652704Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed ConditionsCompletedNCT01380496Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Leflunomide Tablets Under Fed ConditionsCompletedNCT00653003Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy TubesTerminatedNCT01994642Phase 3
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Propranolol Under Fed ConditionsCompletedNCT00652600Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Tramadol/APAP Tablets Under Fed ConditionsCompletedNCT00652821Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis ExternaTerminatedNCT01910155Phase 3
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated SuspensionTerminatedNCT00637403Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer PatientsTerminatedNCT00637728Phase 3
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated SuspensionTerminatedNCT00637806Phase 3
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Equivalence Study of Specificity of PPDStatus unknownNCT01798095Phase 2
Sponsor listed in the registry: JHP Pharmaceuticals LLC · First submitted before JHP Pharmaceuticals LLC became part of Par Health
- Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)Status unknownNCT01798121Phase 2
Sponsor listed in the registry: JHP Pharmaceuticals LLC · First submitted before JHP Pharmaceuticals LLC became part of Par Health
- Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)Status unknownNCT01689831Phase 2
Sponsor listed in the registry: JHP Pharmaceuticals LLC · First submitted before JHP Pharmaceuticals LLC became part of Par Health
- Evaluation of Clinical Equivalence Between Two Lubiprostone ProductsCompletedNCT01372423Phase 3
Sponsor listed in the registry: Anchen Pharmaceuticals, Inc · First submitted before Anchen Pharmaceuticals, Inc became part of Par Health
- Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%CompletedNCT01456611Phase 3
Sponsor listed in the registry: Anchen Pharmaceuticals, Inc · First submitted before Anchen Pharmaceuticals, Inc became part of Par Health
- A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food StudyCompletedNCT01380431Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting ConditionsCompletedNCT01380457Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Metronidazole Capsules Under Fed ConditionsCompletedNCT01380522Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Metronidazole Capsules Under Fasting ConditionsCompletedNCT01380509Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting ConditionsCompletedNCT01380483Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Comparative Bioavailability Study of Lisinopril Tablets, 10 mgCompletedNCT01375244Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Torsemide Tablets Under Fasting ConditionsCompletedNCT00653549Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00659074Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00659685Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed ConditionsCompletedNCT00653458Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Torsemide Tablets Under Fed ConditionsCompletedNCT00654043Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00654277Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Tramadol/APAP Tablets Under Fasting ConditionsCompletedNCT00653315Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Propranolol Under Fasting ConditionsCompletedNCT00653120Phase 2
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting ConditionsCompletedNCT00653380Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Leflunomide Tablets Under Fasting ConditionsCompletedNCT00652665Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Oxandrolone Tablets Under Fasting ConditionsCompletedNCT00652886Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Clonazepam ODT Under Fasting ConditionsCompletedNCT00652912Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Clonazepam Tablets Under Fasting ConditionsCompletedNCT00652639Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting ConditionsCompletedNCT00653055Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting ConditionsCompletedNCT00652795Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting ConditionsCompletedNCT00653419Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health
- Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting ConditionsCompletedNCT00653393Phase 1
Sponsor listed in the registry: Par Pharmaceutical, Inc. · First submitted before Par Pharmaceutical, Inc. became part of Par Health